Molina Healthcare's stock price fell sharply by 5.06% during intraday trading on Monday, as the healthcare company faced significant downward pressure from Wall Street analysts.

The decline came after several major financial firms, including Cantor Fitzgerald, Jefferies, UBS, and TD Cowen, all lowered their price targets for Molina Healthcare. Cantor Fitzgerald reduced its target to $144 from $180 while maintaining a Neutral rating, Jefferies cut its target to $139 from $160, UBS lowered its target to $145 from $170, and TD Cowen reduced its target to $144 from $175.

These simultaneous price target reductions from multiple analysts created negative sentiment around the stock, leading to the significant intraday sell-off. The consensus among analysts appears to be shifting to a more cautious outlook on Molina Healthcare's near-term prospects.